Search
Powered By HealthLine
Special Offers
Health Tools
 Video: Causes of Acne
 Tanning and Skin Health
 Treatment for Aging Skin
 Healthy Beauty Tips
 Skin Cancer Prevention
Featured Conditions
 Skin Care
 Skin Cancer
 Sleep
 Food & Fitness
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Beta Blocker May Shrink Infant Hemangiomas

Blood pressure drug reduced color, size of disfiguring vessel growths, researcher says

By Serena Gordon
HealthDay Reporter


Related Encyclopedia
 border=
Acne
Alagille Syndrome
Appendicitis
Asthma in Children
More...

Related Healthscout Videos
 border=
Picture Perfect Smile
You Sure Could Use Some Sun
Space Age Dental Scan
Bioengineering versus Avian-Based HA?
More...

Related Animations
 border=
Acne
Dental Cavities
Eczema
More...

Related Drug Information
 border=
Adderal XR
Bactroban Cream
Bactroban Ointment
Concerta
More...

Related News Articles
 border=
Scientists ID 2 New Genes for Bowel Disease in Kids
Think You Are Lead-Free? Check Your Soil
Kids' Fever Time Cut Using Ibuprofen First
Non-Hospital Baby Abductions a New Concern
More...

WEDNESDAY, June 11 (HealthDay News) -- New research suggests that a blood pressure medication can shrink abnormal and sometimes disfiguring growths of blood vessels in infants known as hemangiomas.

When using propranolol to treat heart conditions in two infants who also had a hemangioma, French researchers noticed that the color and size of the hemangioma was reduced within a day for both babies.

Text Continues Below



"We have serendipitously observed that propranolol can inhibit the growth phase of infant hemangioma in two consecutive infants," said Dr. Christine Leaute-Labreze, from the department of pediatric dermatology at Bordeaux Children's Hospital in France.

"After informed consent was obtained from the parents, propranolol was given to nine additional patients who had severe or disfiguring infant hemangiomas. In all cases, 24 hours after the onset of treatment, we observed a change in color from intense red to purple, associated with a palpable softening of the lesion," she said.

Results of the study were published as a letter in the June 12 issue of the New England Journal of Medicine.

Hemangiomas, commonly seen as red lesions, are usually found in the top layers of the skin, but sometimes, they grow much deeper. Although they're noncancerous, they can be disfiguring.

Most hemangiomas grow for about nine months, according to Dr. Robin Gehris, chief of pediatric dermatologic surgery at Children's Hospital of Pittsburgh. "Their natural history is that they behave similar to placental tissue. They actively proliferate for about nine months, then stabilize, and then [decrease] about 10 percent a year until they're gone," she said, adding that without treatment most are gone by the time a child is 10.

If a hemangioma is growing near the eye, mouth or airway, Gehris said that treatment will often be given. The most common treatment for more serious hemangiomas is corticosteroids. Other medications that can be used include vincristine (a chemotherapy medication) and interferon.

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 6/11/2008

Related Links
 border=
From Healthscout's partner site on skin cancer, SkinCancerConnection.com
VIDEO: Shock treatment for melanoma successful
SYMPTOMS: Images and information on skin cancer symptoms
Sunburn First Aid - Tips for Preventing Sunburn





New Features

New ADHD Site!

SOURCES: Christine Leaute-Labreze, M.D., department of pediatric dermatology, Bordeaux Children's Hospital, and The National Center for Rare Skin Disorders of Bordeaux, France; Robin Gehris, chief, pediatric dermatologic surgery, Children's Hospital of Pittsburgh; June 12, 2008, New England Journal of Medicine


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map